FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs
High caution: active diabetes on multiple medications People with type 2 diabetes who are actively taking insulin, sulfonylureas, or SGLT2 inhibitors alongside semaglutide face significantly elevated hypoglycemia and euDKA risk when adding keto
Research shows that patients continue losing weight through weeks 1624, with cumulative losses of 1015% of starting body weight in clinical trials
Thyroid tumours Mounjaro carries a boxed warning based on findings in animal studies, and isnt recommended for anyone with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia type 2
A provider can use these insights alongside your genetic predispositions to inform treatment selection, rather than defaulting to whichever drug showed larger average weight loss in trials
Unlike automated weight loss platforms, Eddie founded Peak Performance to bring clinical excellence and personalized care together in one place